Phase 2 study of TZP-102 for diabetic gastroparesis - ONA

Links shared publicly online about this topic.

  • 1,059
    total visits

Phase 2 study of TZP-102 for diabetic gastroparesis - ONA

oncologynurseadvisor.com

Tranzyme Pharma announced positive results from its Phase 2 study of TZP-101 for the treatment of gastroparesis in patients with diabetes mellitus (DM).

View full resource at oncologynurseadvisor.com

Tags: Diabetes, Pharma, Phase 2 Clinical Trial

  • Share

Most Recently Shared on June 29, 2010 at 3:42 pm By:

ONAcom OncologyNurseAdvisor

Phase 2 study of TZP-102 for diabetic gastroparesis http://goo.gl/fb/Saq7E

2 years ago...

Phase 2 study of TZP-102 for diabetic gastroparesis - MPR

empr.com — “Tranzyme Pharma announced positive results from its Phase 2 study of TZP-101 for the treatment of gastroparesis in patients with diabetes mellitus (DM).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on June 29, 2010 at 3:18 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 2 study of TZP-102 for diabetic gastroparesis: Tranzyme Pharma announced positive results from its... http://bit.ly/dbtPYG

2 years ago...

Advertisement